| Patents for A61P 13 - Drugs for disorders of the urinary system (56,135) |
|---|
| 10/01/2008 | EP1331935B1 Derivatives of tryptamine and analogous compounds, and pharmaceutical formulations containing them |
| 10/01/2008 | EP1212295B1 Substituted alpha-hydroxy acid caspase inhibitors and the use thereof |
| 10/01/2008 | CN101277932A Aryl-substituted nitrogen-containing heterocyclic compound |
| 10/01/2008 | CN101277926A Method of obtaining 3,3-diphenylpropylamines |
| 10/01/2008 | CN101277707A Pharmaceutical compositions comprising of arsenous acid, its sodium salt and its derivatives intended for the treatment of urogenital cancer and its metastasis |
| 10/01/2008 | CN101275136A Polypeptides controlling phosphoric acid metabolism, calcium metabolism, calcification and vitamin d metabolism and DNAs encoding the same |
| 10/01/2008 | CN101274086A Paste for purging heat and treating stranguria |
| 10/01/2008 | CN101274084A Medicament for curing hypertension, hyperlipemia and complication thereof |
| 10/01/2008 | CN101274075A Chinese medicine for curing uremia |
| 10/01/2008 | CN101274069A Compound formulation of capsules for curing nephritis and preparing technique |
| 10/01/2008 | CN101274060A Loins-strengthening and kidney-invigorating paste |
| 10/01/2008 | CN101274059A Method for preparing black plaster |
| 10/01/2008 | CN101274036A Method for testing quality criteria of conghuang preparation for tonifying kidney |
| 10/01/2008 | CN101274030A Compound formulation of capsules for invigorating yang and preparing technique |
| 10/01/2008 | CN101274008A Sustained-release dropping pill of Tripterygium glycosides and method of preparing the same |
| 10/01/2008 | CN100422316C Neutralizing human anti-IGFR antibody |
| 10/01/2008 | CN100422315C Isolated homozygous stem cells differentiated cells derived therefrom and materials and methods for making and using same |
| 10/01/2008 | CN100422160C Novel morpholine derivatives, method for production thereof and pharmaceutical preparations containing said derivatives |
| 10/01/2008 | CN100421711C Chinese medicinal composition for treating urinamid |
| 10/01/2008 | CN100421705C Method of extracting compound male moth hidney fortifying raw material possesing improving sexual living quality from pure Chinese medicinal preparation |
| 10/01/2008 | CN100421687C Chinese medicine for treating kidney insufficiency |
| 10/01/2008 | CN100421677C Use of stub-like bacillus prepn. or acellular stub-like bacillus prepn. |
| 10/01/2008 | CN100421666C Epristeride slow release preparation |
| 10/01/2008 | CN100421654C Use of 1-phenyl-3-dimethylaminopropane compounds for treating urinary incontinence |
| 09/30/2008 | US7429618 substituted triarylmethane compounds for immunosuppressive treatment of autoimmune disorders or inflammatory diseases; [Tris-(4-fluoro-phenyl)-methyl]-phosphonic acid dimethyl ester; Gardos channel antagonists |
| 09/30/2008 | US7429607 5-HT2B receptor antagonists |
| 09/30/2008 | US7429592 treating diseases that are triggered by persistent angiogenesis; inhibition of the VEGF receptor |
| 09/30/2008 | US7429584 Furo[2.3-b]pyridine derivatives for the treatment of hyper-proliferative disorders |
| 09/30/2008 | US7429574 4-heterocyclo-pyrrolo[2,3d] pyrimidine compositions and their use |
| 09/30/2008 | US7429564 Orally administering insulin and delivery agent 4-[(4-chloro, 2-hydroxybenzoyl)amino]butanoic acid that facilitates the absorption of insulin from the gastrointestinal tract; diabetes mellitus; bioavailability comparable to injection; treating diabetes without the drawbacks of systemic hyperglycemia |
| 09/30/2008 | US7429559 Controlled release composition and method of producing the same |
| 09/30/2008 | US7429488 Method for processing lipoaspirate cells |
| 09/30/2008 | US7429387 Administering neurotoxin |
| 09/30/2008 | CA2505933C Use of botulinum toxin for treating urinary incontinence |
| 09/30/2008 | CA2323363C Novel compositions of eprosartan |
| 09/30/2008 | CA2261989C Recombinant pox virus for immunization against tumor-associated antigens |
| 09/30/2008 | CA2183050C Sulfonyl- or sulfinylbenzoylguanidine derivatives |
| 09/25/2008 | WO2008114819A1 Novel adenine compound |
| 09/25/2008 | WO2008114817A1 Novel adenine compound |
| 09/25/2008 | WO2008114679A1 Bone metabolism ameliorating agent |
| 09/25/2008 | WO2008113095A1 Compositions and therapies comprising tranilast compounds and angiotensin-converting enzyme (ace) inhibitors and/or angiotensin receptor blockers (arb) |
| 09/25/2008 | WO2008084319A3 Novel nucleic acid |
| 09/25/2008 | WO2007146262A3 Method for treating renal disease |
| 09/25/2008 | US20080234467 Modifying amino acid sequences conjugate comprising: coupling N- alpha -protected amino acid to an immobilized peptide sequence, deprotecting sequence, cleaving peptide conjugate, recovering product |
| 09/25/2008 | US20080234375 Process for Decreasing Environmental Pollutants in an Oil or a Fat, a Volatile Environmental Pollutants Decreasing Working Fluid, a Health Supplement, and an Animal Feed Product |
| 09/25/2008 | US20080234346 Pyrazalidinone compounds as ligands of the prostaglandin ep2 and/or ep4 receptors |
| 09/25/2008 | US20080234316 Quinuclidine Amide Derivatives |
| 09/25/2008 | US20080234280 Use of Mc4 Receptor Agonist Compounds |
| 09/25/2008 | US20080234266 Squaric Acid Derivatives II |
| 09/25/2008 | US20080234221 Transferring agent into cells; using polypeptides, polynucleotides, antibodies nucleic acids ; tumor suppressor gene; anticancer agents |
| 09/25/2008 | US20080234214 Seven or more contiguous ribose groups linked by achiral 5' to 3' internucleoside phosphate linkages; antisense agents for gene expression inhibition of a wide variety of pathological disorders such as autoimmune diseases; suitable for oral administration |
| 09/25/2008 | US20080234209 Derivatives of N-methyl-N-[(1S)-1-phenyl-2-((3S)-3-hydroxypyrrolidin-1-yl)ethyl]-2,2-diphenylacetamide; for preparation of drugs, gastrointestinal tract disease |
| 09/25/2008 | US20080233185 Using dimethyl fumarate and/or diethyl fumarate, calcium alkyl fumarate, calcium methyl fumarate and/or calcium ethyl fumarate, zinc methyl fumarate and/or zinc ethyl fumarate, methyl hydrogen fumarate and/or ethyl hydrogen fumarate; sclerodermia, osteochondritis syphilitica (Wegener's disease) |
| 09/25/2008 | US20080233091 use of a live culture of a non-pathogenic food-grade probiotic bacterium ( lactococcus or lactobacillus strains of lactic acid bacteria) in the treatment of infectious diseases, may be a localised infection of the skin, including an infected wound, a urinary tract infection or mastitis |
| 09/25/2008 | US20080233079 Crosslinked amine polymers |
| 09/25/2008 | CA2680397A1 Novel adenine compound |
| 09/24/2008 | EP1971369A2 Combination of anticholinergics, glucocorticoids, beta2-agonists, pde4 inhibitor and antileukotriene for the treatment of inflammatory diseases |
| 09/24/2008 | EP1971358A1 A method of treatment |
| 09/24/2008 | EP1537096B1 Derivatives of dioxane-2-alkyl carbamates, preparation method thereof and application of same in therapeutics |
| 09/24/2008 | EP1513520B1 Substituted pyrrolines as kinase inhibitors |
| 09/24/2008 | EP1411128B1 Recombinant viral vectors containing the human urokinase plasminogen activator gene and their utilization in the treatment of hepatic fibrosis |
| 09/24/2008 | EP1292315B1 Use of sulodexide for the treatment of diabetic nephropathy |
| 09/24/2008 | CN101270107A Medicament for preventing and treating prostate gland hyperplasia, abacterial prostatitis |
| 09/24/2008 | CN101269213A Soluble preparation of bone morphogenesis protein-7 and application thereof |
| 09/24/2008 | CN101269187A Medicament composition for treating bladder cancer and preparation method thereof |
| 09/24/2008 | CN101269181A Phragmites communis trin kuh-seng soup |
| 09/24/2008 | CN101269180A Traditional Chinese medicine compound preparation for treating nephritis and preparation method |
| 09/24/2008 | CN101269165A Medicament for treating stomach, sausage and nephrocolic |
| 09/24/2008 | CN101269139A Medicine for treating nephritis type haematuria |
| 09/24/2008 | CN101269064A Application of myricetin in medicament for treating prostate gland disease |
| 09/24/2008 | CN101269047A Tolterodine tartrate sustained-release dropping pill and preparation method thereof |
| 09/24/2008 | CN101269036A Doxazosin mesylate sustained-release dropping pill and preparation method thereof |
| 09/24/2008 | CN101269022A Darifenacin hydrobromide sustained-release dropping pills and preparation method thereof |
| 09/24/2008 | CN101268843A Babaoshan chicken soup and preparing technique |
| 09/24/2008 | CN101268831A Truffle hydrophilic solvent extract and application of the same in preparing food, health food, and medicament for treating prostate gland disease etc. |
| 09/24/2008 | CN100420682C Separating preparation process of salvianolic acid B |
| 09/24/2008 | CN100420484C Human lysozyme suppository, preparation method and application |
| 09/24/2008 | CN100420481C Compound Chinese medicine preparation for treating prostatic disease |
| 09/24/2008 | CN100420452C Application of total asiaticoside in preparing medicine for preventing and treating membranous nephropathy |
| 09/24/2008 | CN100420441C Use of flavone in preparing medicine for improving uric acid excretion |
| 09/23/2008 | US7427681 Anticancer agents; antidiabetic agents; Alzheimer's disease |
| 09/23/2008 | US7427631 especially as inhibitors of MMP12 |
| 09/23/2008 | US7427623 4-Amino-2,3-disubstituted thieno[2,3-d]pyrimidines and pharmacetical compositions thereof |
| 09/23/2008 | US7427613 7-aryl-3,9-diazabicyclo(3.3.1)non-6-ene derivatives and their use as renin inhibitors in the treatment of hypertension, cardiovascular or renal diseases |
| 09/23/2008 | CA2432872C Pyrazole compounds useful as protein kinase inhibitors |
| 09/23/2008 | CA2418313C Piperidine derivatives and agent comprising the derivative as active ingredient |
| 09/23/2008 | CA2379747C Novel succinate derivative compounds useful as cysteine protease inhibitors |
| 09/23/2008 | CA2338256C Bioenhanced formulations comprising eprosartan in oral solid dosage form |
| 09/23/2008 | CA2310055C New urethanes, the thio and dithio analogues thereof,the salts thereof, pharmaceutical compositions containing these compounds and their use as well as process for preparing them |
| 09/18/2008 | WO2008111450A1 Sphingosine compound, method for producing the same, and sphingomyelinase inhibitor |
| 09/18/2008 | WO2008086834A3 Pharmaceutical composition for treating incontinence |
| 09/18/2008 | US20080227954 Therapeutic amino acid sequences for use in treatment and prevention of viral, infectious, cancerous, diabetic, incontinent, hypertensive and nervous system disorders |
| 09/18/2008 | US20080227843 Therapeutic use of n-(1h-indolyl)-1h-indole-2-carboxamide derivatives |
| 09/18/2008 | US20080227833 Selective inhibitors of MMP-9 and/or MMP12; antiinflammatory agents for multiple sclerosis and fibrosis; 3R-[2,2-Dimethyl-1 S-(5-phenyl-[1,2,4]oxadiazol-3-yl)-propylcarbamoyl]-2S-hydroxy-5-methyl-hexanohydroxamic acid; bone resorption, metastases, rheumatoid arthritis, Crohn's disease |
| 09/18/2008 | US20080227789 5-(quinoxalin-2-yl)-N2-(3,4,5-trimethoxyphenyl)thiazole-2,4-diamine; useful in inhibiting the activity of the receptor protein tyrosine kinase Axl; rheumatoid arthritis, vascular disease, vascular injury, psoriasis, visual impairment due to macular degeneration, diabetic retinopathy, retinopathy |
| 09/18/2008 | US20080227770 Benzoxazepine Compound |
| 09/18/2008 | US20080227127 Human NK3-Related Prostate Specific Gene-1 |
| 09/18/2008 | US20080226738 Sustained-Released Pellet Formulation of Alpha1-Receptor Antagonist and Process For the Preparation Thereof |
| 09/18/2008 | US20080226697 Mixture of transdermal absorption promoter and drug; stabilized with polyvinylpyrrolidone; prevent vaporization or degradation |
| 09/18/2008 | US20080226683 Potentiating clinoptilolite via saline wash and drying; medicant filler materials; removing metals, nitrates and toxins from organ tissues |